# OnCo record nct07739654 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07739654/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07739654", "NCT07739654" ;
  schema:name "Modified against standard DHAP salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma (Lahore)"@en ;
  schema:description "A Lahore trial testing whether splitting two chemotherapy drugs into smaller doses over two days works as well for lymphoma that has come back, with less harm to the kidneys and without a hospital stay."@en ;
  schema:url <https://onco.cc/trials/nct07739654/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07739654> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2026-03-18" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:institutions <https://onco.cc/institutions/kemu-lahore/> .